New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Cancer drug insight tactic could spell double trouble for tumours

Cancer drug insight tactic could spell double trouble for tumours

by University of EdinburghScientists hope to identify cancer drugs that work in a two-pronged approach -- by inducing errors when cancer cells divide packages of their DNA -- known as chromosomes
Oncology March 08,2024
Cancer drug insight tactic could spell double trouble for tumours

Cancer drug insight tactic could spell double trouble for tumours

by University of EdinburghScientists hope to identify cancer drugs that work in a two-pronged approach -- by inducing errors when cancer cells divide packages of their DNA -- known as chromosomes
Oncology March 08,2024
Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new
Oncology March 08,2024
Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new
Oncology March 08,2024
Leukemia, lymphoma squarely in sights of new class of drugs

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d
Oncology March 08,2024
Leukemia, lymphoma squarely in sights of new class of drugs

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d
Oncology March 08,2024
Startup helps identify patients at risk for hereditary cancers

Startup helps identify patients at risk for hereditary cancers

by Greta Guest,University of MichiganCredit: CC0 Public DomainUniversity of Michigan startup InheRET Inc. has launched an online program that helps identify patients at risk for hereditary cance
Oncology March 08,2024
Startup helps identify patients at risk for hereditary cancers

Startup helps identify patients at risk for hereditary cancers

by Greta Guest,University of MichiganCredit: CC0 Public DomainUniversity of Michigan startup InheRET Inc. has launched an online program that helps identify patients at risk for hereditary cance
Oncology March 08,2024
Does marital status affect prognosis after breast cancer diagnosis?

Does marital status affect prognosis after breast cancer diagnosis?

by WileyCredit: CC0 Public DomainIn aCancer Medicinestudy of 298,434 patients diagnosed with breast cancer between 2004 and 2012, married patients had a better prognosis than patients
Oncology March 08,2024
Does marital status affect prognosis after breast cancer diagnosis?

Does marital status affect prognosis after breast cancer diagnosis?

by WileyCredit: CC0 Public DomainIn aCancer Medicinestudy of 298,434 patients diagnosed with breast cancer between 2004 and 2012, married patients had a better prognosis than patients
Oncology March 08,2024
Thousands of cervical screening samples are waiting to be tested, says report

Thousands of cervical screening samples are waiting to be tested, says report

by Cancer Research UKCredit: CC0 Public DomainMore than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.A study fr
Oncology March 08,2024
Thousands of cervical screening samples are waiting to be tested, says report

Thousands of cervical screening samples are waiting to be tested, says report

by Cancer Research UKCredit: CC0 Public DomainMore than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.A study fr
Oncology March 08,2024
One dose of radiotherapy as effective as five doses for cancer in the spine

One dose of radiotherapy as effective as five doses for cancer in the spine

by University College LondonCredit: CC0 Public DomainA single dose of radiotherapy is as "effective" as five doses for end-of-life cancer patients suffering with painful spinal canal co
Oncology March 08,2024
One dose of radiotherapy as effective as five doses for cancer in the spine

One dose of radiotherapy as effective as five doses for cancer in the spine

by University College LondonCredit: CC0 Public DomainA single dose of radiotherapy is as "effective" as five doses for end-of-life cancer patients suffering with painful spinal canal co
Oncology March 08,2024
Transplant medication matters for controlling cancer risk

Transplant medication matters for controlling cancer risk

by University of QueenslandCredit: University of QueenslandResearch reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppres
Oncology March 08,2024
Transplant medication matters for controlling cancer risk

Transplant medication matters for controlling cancer risk

by University of QueenslandCredit: University of QueenslandResearch reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppres
Oncology March 08,2024
New analyses demonstrate link between different forms of menopausal hormone therapy and breast cancer incidence

New analyses demonstrate link between different forms of menopausal hormone therapy and breast cancer incidence

by LancetMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAn international collaboration, using data from more than 100,000 women with breast cance
Oncology March 08,2024
New analyses demonstrate link between different forms of menopausal hormone therapy and breast cancer incidence

New analyses demonstrate link between different forms of menopausal hormone therapy and breast cancer incidence

by LancetMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAn international collaboration, using data from more than 100,000 women with breast cance
Oncology March 08,2024
Immune stimulant molecule shown to prevent cancer

Immune stimulant molecule shown to prevent cancer

by Etty Coffman,University of LouisvilleA confocal microscope image shows the SA-4-1BBL (green color) bound to its receptor on an immune cell (red color) to initiate an immune activation cascade
Oncology March 08,2024
Immune stimulant molecule shown to prevent cancer

Immune stimulant molecule shown to prevent cancer

by Etty Coffman,University of LouisvilleA confocal microscope image shows the SA-4-1BBL (green color) bound to its receptor on an immune cell (red color) to initiate an immune activation cascade
Oncology March 08,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com